Artiva Biotherapeutics
The Associate Director of Regulatory Affairs, CMC at Artiva Biotherapeutics supports late-stage development, commercial launch, and lifecycle management of cell therapy products. This role involves authoring and reviewing regulatory submissions, managing global health authority interactions, and ensuring compliance with scientific and regulatory standards.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2019
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for autoimmune diseases. Their lead product candidate, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) across multiple clinical trials, including basket trials in rheumatoid arthritis and Sjögren's disease. The company leverages highly scaled, off-the-shelf, allogeneic NK cell manufacturing to make cell therapies broadly accessible to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Artiva Biotherapeutics.
24% above the average for this role
Regulatory Director/Sr. Director Regulatory CMC
Beam Therapeutics
Regulatory CMC
argenx
Senior Director, CMC Regulatory
Kardigan
Executive Director, CMC Regulatory Science
Moderna
Director/Sr. Director Regulatory CMC, Lilly Regenerative Medicine
Eli Lilly and Company
Senior Expert Regulatory Affairs - CMC/Biosimilars
gloorlang